Home Case study AstraZeneca – Pfizer Bid

AstraZeneca – Pfizer Bid

by Nigel Kendall

AstraZeneca – Pfizer’s bid raises questions over the future of giant pharmaceutical companies

The attempt by Pfizer to achieve the takeover of AstraZeneca with the recommendation of the board of its rival has captured the attention of all those with a direct interest in the result and many others besides.

This in-depth article by Nigel  analyses the saga and considers the lessons to be learned from the takeover attempt, examining it against our Five Golden Rules of corporate governance. Covered in the article is the following:

Issues at stake:

  • Industry’s strategic issues
  • Incentive misalignments

The competing points of view:

  • Who shouts loudest? 
  • Moderate…

Please register to access this content.

Related Articles

Leave a Comment